Skip to main content
. 2019 Jul 30;65(3):203–215. doi: 10.5606/tftrd.2019.1894

Table 1. Demographic and clinical characteristics of women and men with and without osteoporosis.

  Women   Men  
  With OP (n=49) Without OP (n=82)   With OP (n=37) Without OP  (n=72)  
Characteristics n % Mean±SD Range n % Mean±SD Range p n % Mean±SD Range n % Mean±SD Range p
Age (year)     55.6±13.0 26-79     52.6±11.2 21-78 0.165*     55.1±13.7 28-80     59.2±13.7 24-85 0.139*
Weight (kg)     68.8±10.4       70.5±12.9   0.431*     75.6±12.8       79.4±13.6   0.167*
Height (m)     1.6±0.1       1.6±0.1   0.109*     1.7±0.1       1.7±0.1   0.976*
BMI (kg/m2)     28.3±4.1       28.2±5.0   0.971*     25.8±3.0       27.2±4.3   0.074*
Menopause 39/10 79.6/20.4     57/25 69.5/30.5     0.207** NA       NA       -
Menopause age (year)     44.3±5.8       46.5±5.6   0.077* NA       NA       -
Estrogen use (ever) 2/47 4.1/95.9     8/74 9.8/90.2     0.320** NA       NA       -
History of previous fracture 4/45 8.2/91.8     8/74 9.8/90.2     1.000** 3/34 8.1/91.9     5/67 6.9/93.1     1.000**
Parent with hip fracture 2/47 4.1/95.9     3/79 3.7/96.3     1.000** 0/100 0.0/100.0     1/71 1.4/98.6     1.000**
Current smoking 10/39 20.4/79.6     15/67 18.3/81.7     0.820* 8/29 21.6/78.4     22/50 30.6/69.4     0.372*
Number of cigarettes (day)     9.5±6.3       11.6±8.2   0.381*     15.3±6.4       18.3±10.2   0.324*
Years smoked     19.2±9.2       22.5±8.1   0.266*     19.2±10.2       24.2±14.9   0.260*
Alcohol use 0/49 0.0/100.0     0/82 0.0/100.0     - 0/37 0.0/100.0     3/69 4.2/95.8     0.324*
Secondary OP causes 23/26 46.9/53.1     30/52 36.6/63.4     0.273** 8/29 21.6/78.4     27/45 37.5/62.5     0.129**
Physical activity 30 61,2     45 54,9     0.808** 10 27,0     24 33,3     0.817**
Low                                    
Moderate 14 28,6     27 32,9       21 56,8     38 52,8      
High 5 10,2     10 12,2       6 16,2     10 13,9      
Diseases                                    
Rheumatoid arthritis 3/46 6.1/93.9   11/71   13.4/86.6   0.250**   0/37 0.0/100.0   0/72   0.0/100.0   -  
Others rheumatic diseases 4/45 8.2/91.8   4/78   4.9/ 95.1   0.471**   2/35 5.4/94.6   9/63   12.59/87.5   0.327**  
Diabetes mellitus 3/46 6.1/93.9   12/70   14.6/85.4   0.166**   2/35 5.4/94.6   19/53   26.4/73.6   0.009**  
Thyroid disease 3/46 6.1/93.9   10/72   12.2/87.8   0.369**   2/35 5.4/94.6   0/72   0.0/100.0   0.113**  
Pulmonary diseases 5/44 10.2/89.8   3/79   3.7/96.3   0.419**   1/36 2.7/97.3   6/ 66   8.3/91.7   0.419**  
Cancer 2/47 4.1/95.9   2/80   2.4/97.6   0.630**   1/36 2.7/97.3   1/ 71   1.4/98.6   1.000**  
Renal insufficiency 1/48 2.0/98.0   1/81   1.2/98.8   1.000**   1/36 2.7/97.3   0/72   0.0/100.0   0.339**  
Corticosteroid use 15/34 30.6/69.4   19/63   23.2/76.8   0.411**   4/33 10.8/89.2   9/63   12.5/87.5   1.000**  
Corticosteroid dose (mg)     12.6±20.3       6.8±6.4 0.316*       6.3±2.5       6.3±3.8 0.715*  
Months of corticosteroids     71.5±82.2       59.5±87.0 0.715*       15.8±14.2       23.2±22.4 0.556*  
OP medication use 8/41 16.3/83.7   2/80   2.4/97.6   0.006**   0/37 0.0/100.0   0/72   0.0/100.0   -  
SD: Standard deviation; BMI: Body mass index; NA: Not applicable; OP: Osteoporosis; * Independent Samples Test; ** Chi-Square test; Yes/No are given for dichotomous data.